GF Fund Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
GF Fund Management's LGND Position: Q3 2026 in Review
GF Fund Management increased its Ligand Pharmaceuticals (LGND) stake by 16% in Q3 2026, buying an estimated $20.7K and bringing the position to 495 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #296.
GF Fund Management first reported a position in LGND in Q4 2024 and has held it in 8 quarters since. 433 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- GF Fund Management held 495 shares of Ligand Pharmaceuticals worth $155K as of Q3 2026.
- GF Fund Management bought 70 Ligand Pharmaceuticals shares in Q3 2026, an estimated $20.7K.
- Ligand Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #296 holding.
- GF Fund Management first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- 433 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.